On November 8, TBCU Chair Dr. Tina Merritt, along with…
This symposium gathered some of the world’s leading medical researchers, scientists, and individuals affected by Alpha-gal Syndrome to exchange insights, share valuable knowledge, and promote awareness and understanding of this condition. Participants will learn the latest research findings, diagnosis, and key areas of support required for AGS patients of all ages.
Presentations include:
- Discovery and History of Alpha-gal and the Contrast Between Alpha-gal and Other Forms of Food Allergy, Thomas Platts-Mills, MD (UVA)
- Clinical Trials Network for Lyme and other Tick-borne Diseases Brian Fallon, MD MPH (CUMC) and Meghan Bradshaw
- Mast Cell Activation Disease: Current Concepts Lawrence Afrin, MD
- AGS in Clinical Practice Tina Merritt, MD (NWA Asthma & Allergy)
- Q&A, Morning Session
- Patient Panel – hosted by Two Alpha Gals; Candice Matthis and Debbie Nicols, and patients; Kenton Pledger, Ken McCullick, and Amanda Warren
- AG-safe medication Review: An Anesthesiology Group’s Protocol; Holly McBryde Mason, MD, FASA
- Alpha-gal Syndrome: Child Safety in Schools; Amanda Warren and Jelisa Wolfe, PhD
- Using a murine model of Alpha-gal Syndrome to study immune responses; Shahid Karim, PhD (USM)
- Gut Reaction: Alpha-gal Syndrome with GI-Predominant Symptoms; Sarah McGill, MD (UNC)
- Thinking About Immediate, Delayed, and Chronic Effect of Alpha-gal Syndrome; Thomas Platts-Mills, MD (UVA)
- Q&A, Afternoon Session
- Wrap-Up and Adjourn
CME Information
Looking for CMEs? If you were not able to watch live and wish to register for CMEs you must fill out this form prior to watching the video. After you have watched the video, click here to register for your CMEs and complete the post-test questionnaire.
Thank you so much for your interest in this groundbreaking symposium. We hope you learn a lot about Alpha-gal Syndrome and are able to incorporate learnings into your daily activities!
In order to offer CMEs for this Symposium (which we felt was very important) we were not allowed to use conference sponsors to fund the event.
Please consider a minimum suggested donation of $35 to cover CME and production expenses (and thanks in advance!).
Save the date for our next Symposium for February 8, 2025!
Warm regards,
Beth Carrison
CoFounder and Director of Advocacy
Jennifer Platt, DrPH
CoFounder and Director of Programs
Accreditation Statement
The School of Medicine of the University of North Carolina at Chapel Hill is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Statement
The School of Medicine of the University of North Carolina at Chapel Hill designates this live activity for a maximum of 6.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure statement
This activity has been planned and implemented under the sole supervision of the Course Director, Jennifer Platt, DrPH, in association with the UNC Office of Continuing Professional Development (CPD). The course director and CPD staff have no relevant financial relationships with ineligible companies as defined by the ACCME.
Dr. McGill holds stock in Abbott Labs and Seattle Genetics and receives research support from Clinical Genomics, EvoEndo, Exact Sciences, Finch Therapeutics (ended 2022), Freenome Holdings (ended 2022), Guardant Health, Polymedco, and Revivicor. Dr. Merrit holds a patent on the test for IgE to Alpha-gal and receives consulting fees from Pharming Group NV and Takeda and is PI of the Paraxel-Astria-STAR clinical trial. The Two Alpha Gals podcast receives support from Insect Shield. These financial relationships have been mitigated. The other speakers and panelists have no relevant financial relationships with ineligible companies as defined by the ACCME.
Donate To Help Fight Tick-Borne Diseases
You’ll Help Fund Education, Research, and Advocacy for the Lesser-Known Tick Conditions.
Related Posts
